AN DER PROGRESSION NICHTALKOHOLISCHER STEATOHEPATITIS (NASH) BETEILIGTE THERAPEUTISCHE ZIELE

• 收藏
• 分享

专利权人:

The Trustees of Columbia University in the City of New York;The Brigham and Women's Hospital, Inc.

发明人:

TABAS, Ira,WANG, Xiaobo,FAROKHZAD, Omid,XU, Xiading

申请号：

EP17786458

公开号：

EP3445385A4

申请日:

2017.04.18

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention relates to methods and compositions for specifically modulating the Hippo pathway transcription factor TAZ (WWTR1), as a therapeutic target for inhibiting or preventing liver conditions including the progression of steatosis-to-NASH in a patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/